The Conversation (0)
TORONTO, ONTARIO–(Marketwired – Nov. 2, 2016) – Mettrum Health Corp. (TSXV:MT.V), a vertically integrated provider of cannabis products, is pleased to announce the renewals of its sales and production licenses at its two Bowmanville facilities. Following these license renewals, Mettrum’s Company-wide total licensed sales and production capacity stands at 5,600 kilograms per annum.
TORONTO, ONTARIO–(Marketwired – Nov. 2, 2016) – Mettrum Health Corp. (TSXV:MT.V), a vertically integrated provider of cannabis products, is pleased to announce the renewals of its sales and production licenses at its two Bowmanville facilities. Following these license renewals, Mettrum’s Company-wide total licensed sales and production capacity stands at 5,600 kilograms per annum.
The Company is also pleased to announce that the phase 2 expansion at its 60,000 square foot state-of-the-art production facility in Bowmanville (“Bowmanville South”) is on track and will double its production capacity to approximately12,000 kg before the end of the fiscal year ending March 31, 2017.
“Our ample capacity to service the needs of our growing client base combined with the expansion of our Bowmanville South facility leaves us very well positioned for growth within this exciting accelerating medical cannabis market and prepared for the recreational cannabis market in the future,” said Michael Haines, Chief Executive Officer of Mettrum.
Read the full press release.
Connect with Mettrum Health Corp. (TSXV:MT.V) to receive an Investor Presentation.
